These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37083142)

  • 41. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
    Suchonwanit P; Rojhirunsakool S; Khunkhet S
    Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minoxidil: a comprehensive review.
    Gupta AK; Talukder M; Venkataraman M; Bamimore MA
    J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia.
    Mehta N; Huang S; Dhura R; Wambier C; do Nascimento Fonesca D; Little S; Goren A
    J Cosmet Dermatol; 2024 Jan; 23(1):339-343. PubMed ID: 37638619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
    Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
    J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.
    Stamatas GN; Wu J; Pappas A; Mirmirani P; McCormick TS; Cooper KD; Consolo M; Schastnaya J; Ozerov IV; Aliper A; Zhavoronkov A
    Cell Cycle; 2017; 16(17):1578-1584. PubMed ID: 28594262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Platelet-Rich Plasma versus 5% Topical Monixidil for the Treatment of Androgenetic Alopecia.
    Afzal G; Ahmed N; Zahoor F; Malik T; Farooq O
    J Coll Physicians Surg Pak; 2024 Jan; 34(1):11-15. PubMed ID: 38185953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective combination therapy with high concentration of Minoxidil and Carboxygas in resistant Androgenetic alopecia: Report of nine cases.
    Nilforooshzadeh MA; Lotfi E; Heidari-Kharaji M; Zolghadr S; Mansouri P
    J Cosmet Dermatol; 2020 Nov; 19(11):2953-2957. PubMed ID: 32162774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss.
    Nussbaum D; Murphy E; Nelson K; Gonzalez-Lopez A; Qureshi A; Schwartz J; Friedman A
    J Drugs Dermatol; 2022 Oct; 21(10):1140-1142. PubMed ID: 36219050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microneedling in androgenetic alopecia; comparing two different depths of microneedles.
    Faghihi G; Nabavinejad S; Mokhtari F; Fatemi Naeini F; Iraji F
    J Cosmet Dermatol; 2021 Apr; 20(4):1241-1247. PubMed ID: 32897622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
    Blume-Peytavi U; Hillmann K; Dietz E; Canfield D; Garcia Bartels N
    J Am Acad Dermatol; 2011 Dec; 65(6):1126-1134.e2. PubMed ID: 21700360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia.
    Faghihi G; Mozafarpoor S; Asilian A; Mokhtari F; Esfahani AA; Bafandeh B; Nouraei S; Nilforoushzadeh MA; Hosseini SM
    Indian J Dermatol Venereol Leprol; 2018; 84(5):547-553. PubMed ID: 30027912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
    Panahi Y; Taghizadeh M; Marzony ET; Sahebkar A
    Skinmed; 2015; 13(1):15-21. PubMed ID: 25842469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow.
    Kozicka K; Łukasik A; Pastuszczak M; Wojas-Pelc A
    Pol Merkur Lekarski; 2019 Feb; 46(272):80-83. PubMed ID: 30830894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
    Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
    Ghonemy S; Alarawi A; Bessar H
    J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients.
    Goren A; Sharma A; Dhurat R; Shapiro J; Sinclair R; Situm M; Kovacevic M; Lukinovic Skudar V; Goldust M; Lotti T; McCoy J
    Dermatol Ther; 2018 Nov; 31(6):e12741. PubMed ID: 30226287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of oral minoxidil in female androgenetic alopecia.
    Vastarella M; Cantelli M; Patrì A; Annunziata MC; Nappa P; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14234. PubMed ID: 32851744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis.
    Zhou Y; Chen C; Qu Q; Zhang C; Wang J; Fan Z; Miao Y; Hu Z
    Dermatol Ther; 2020 Jul; 33(4):e13741. PubMed ID: 32478968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accelerated hair growth by combining thread monofilament and minoxidil in female androgenetic alopecia.
    Khattab FM; Bessar H
    J Cosmet Dermatol; 2020 Jul; 19(7):1738-1744. PubMed ID: 31789457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.